Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 956

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Nanoparticles in cancer therapy and diagnosis

Brigger, Irène, Dubernet, Catherine, Couvreur, Patrick·2012·Advanced Drug Delivery Reviews

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2012.09.006

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. Krishna, 2000, Multidrug resistance (MDR) in cancer—mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs, Eur. J. Cancer Sci., 11, 265
  2. Brasseur, 1980, Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor, Eur. J. Cancer, 10, 1441, 10.1016/0014-2964(80)90053-5 · doi:10.1016/0014-2964(80)90053-5
  3. Manil, 1995, Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles, Pharm. Res., 12, 85, 10.1023/A:1016290704772 · doi:10.1023/a:1016290704772
  4. Blagoeva, 1992, Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles, Mutat. Res., 268, 77, 10.1016/0027-5107(92)90085-G · doi:10.1016/0027-5107(92)90085-g
  5. Sharma, 1996, Novel taxol® formulation: polyvinylpyrrolidone nanoparticles-encapsulated taxol® for drug delivery in cancer therapy, Oncol. Res., 8, 281
  6. Sakakura, 1992, Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles, Anti-Cancer Drugs, 3, 233, 10.1097/00001813-199206000-00005 · doi:10.1097/00001813-199206000-00005
  7. Hagiwara, 1997, Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer—a pilot study, Anti-Cancer Drugs, 8, 666, 10.1097/00001813-199708000-00004 · doi:10.1097/00001813-199708000-00004
  8. Schwab, 1994, Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice, Proc. Natl. Acad. Sci. USA, 91, 10460, 10.1073/pnas.91.22.10460 · doi:10.1073/pnas.91.22.10460
  9. Chavany, 1994, Adsorption of oligonucleotides onto poly(isohexylcyanoacrylate) nanoparticles protects them against nucleases and increases their cellular uptake, Pharm. Res., 11, 1370, 10.1023/A:1018923301967 · doi:10.1023/a:1018923301967
  10. Godard, 1995, Antisense effect of cholesterol–oligodeoxynucleotide conjugates associated with poly(alkylcyanoacrylate) nanoparticles, Eur. J. Biochem., 232, 404, 10.1111/j.1432-1033.1995.tb20825.x · doi:10.1111/j.1432-1033.1995.tb20825.x
  11. Tondelli, 1998, Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres, Nucleic Acids Res., 26, 5425, 10.1093/nar/26.23.5425 · doi:10.1093/nar/26.23.5425
  12. Zimmer, 1999, Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers, Methods: A Companion to Methods in Enzymology, 18, 286, 10.1006/meth.1999.0786 · doi:10.1006/meth.1999.0786
  13. Ganachaud, 1997, Adsorption of single-strand DNA fragments onto cationic aminated latex particles, Langmuir, 13, 701, 10.1021/la960896e · doi:10.1021/la960896e
  14. Hu, 1996, On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance, Cancer Chemother. Pharmacol., 37, 556, 10.1007/s002800050428 · doi:10.1007/s002800050428
  15. Astier, 1988, Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells, Cancer Res., 48, 1835
  16. Nafziger, 1995, Synthesis and antiproliferative effects of a 4′-morpholino-9-methyl anthracycline, J. Antibiot., 48, 1185, 10.7164/antibiotics.48.1185 · doi:10.7164/antibiotics.48.1185
  17. Leo, 1997, General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles, Il Farmaco, 52, 385
  18. Bhalgat, 1998, Green- and red-fluorescent nanospheres for the detection of cell surface receptors by flow cytometry, J. Immunol. Methods, 219, 57, 10.1016/S0022-1759(98)00121-5 · doi:10.1016/s0022-1759(98)00121-5
  19. Väisänen, 2000, Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies, Luminescence, 15, 389, 10.1002/1522-7243(200011/12)15:6<389::AID-BIO626>3.0.CO;2-7 · doi:10.1002/1522-7243(200011/12)15:6<389::aid-bio626>3.0.co;2-7
  20. Santra, 2001, Development of novel dye-doped silica nanoparticles for biomarker application, J. Biomed. Opt., 6, 160, 10.1117/1.1353590 · doi:10.1117/1.1353590
  21. Wisner, 1996, Indirected computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model, Acad. Radiol., 3, 40, 10.1016/S1076-6332(96)80331-X · doi:10.1016/s1076-6332(96)80331-x
  22. Wisner, 1996, Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles, Acad. Radiol., 3, S257, 10.1016/S1076-6332(96)80551-4 · doi:10.1016/s1076-6332(96)80551-4
  23. Clément, 1994, Magnetic resonance lymphography—Enhancement patterns using superparamagnetic nanoparticles, Invest. Radiol., 29, S226, 10.1097/00004424-199406001-00075 · doi:10.1097/00004424-199406001-00075

Cited by

See all 956

Metadata

Authors
Brigger, I., Dubernet, C., & Couvreur, P.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2012-12
Volume
64
Pages
24-36
ISSN
0169-409X (ISSN-L)
OpenAlex
W4232680877
Cited by
956
References
72
FWCI
1.86
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.